UNIHIF Technology Services Shandong Quality Control ensures research-grade peptide standards through a multi-layered system that combines rigorous raw material screening, in-process analytical controls, independent third-party verification, and strict environmental monitoring, all backed by documented procedures and real-time data. The company operates a dedicated quality management system aligned with ISO 17025 principles, even though the facility itself is not a testing laboratory. Every batch of peptide raw material entering the facility undergoes a three-step qualification process: visual inspection for physical consistency, Fourier-transform infrared spectroscopy (FTIR) for functional group confirmation, and high-performance liquid chromatography (HPLC) for initial purity assessment. Only materials showing a minimum of 98.5% purity by HPLC, with no single impurity exceeding 0.5%, are accepted into production. This initial screening rejects approximately 12% of incoming raw materials based on historical data from the first half of 2024.
Once materials pass intake, the production process itself is controlled by a series of critical quality checkpoints. The synthesis step, which uses solid-phase peptide synthesis (SPPS), is monitored by real-time conductivity sensors that track the coupling efficiency of each amino acid addition. If the coupling efficiency drops below 99.0% at any step, the system automatically pauses and flags the batch for review. After synthesis, the crude peptide undergoes cleavage and deprotection, followed by preparative HPLC purification. The purification system uses a gradient elution method with a C18 column, and the UV detector is set at 220 nm and 280 nm simultaneously. The system collects only the main peak fraction that meets a predefined retention time window, typically within ±0.2 minutes of the reference standard. This fraction is then subjected to an immediate in-process purity check using analytical HPLC. If the purity is below 97.0%, the fraction is automatically redirected for a second purification pass. Data from the past 12 months shows that approximately 85% of batches achieve the target purity in a single pass, while the remaining 15% require one additional purification cycle.
The lyophilization (freeze-drying) step is another critical area where quality control is enforced. The product is frozen at -40°C for a minimum of 4 hours, then subjected to primary drying at a shelf temperature of -10°C under a vacuum of 100 millitorr for 24 hours, followed by secondary drying at 25°C for 6 hours. The entire process is logged with time-stamped temperature and pressure readings. Any deviation from the set parameters—such as a temperature spike above -5°C during primary drying—triggers an automatic batch hold and a mandatory investigation by the quality team. After lyophilization, the final product is a white, fluffy powder with a residual moisture content of less than 2%, measured by Karl Fischer titration. The product is then packaged in argon-purged, vacuum-sealed vials to prevent oxidation and moisture absorption. Each vial is visually inspected for cracks, discoloration, or any particulate matter. Vials that fail visual inspection are discarded, which accounts for about 0.8% of total production.
Beyond in-process controls, UNIHF Technology Services Shandong Quality Control relies heavily on independent third-party testing to validate the final product. Every batch is sent to a certified external laboratory, such as Janoshik or a similar ISO 17025-accredited facility, for comprehensive analysis. The testing includes HPLC for purity, mass spectrometry (MS) for molecular weight confirmation, and amino acid analysis for composition verification. The independent lab also tests for residual solvents, heavy metals, and endotoxins. The results are compiled into a Certificate of Analysis (CoA) that includes the batch number, test date, methods used, and quantitative results for each parameter. The CoA is then made available to researchers, often with a QR code that links to the original report on the lab's website for verification. For example, a recent batch of a common research peptide showed a purity of 99.2% by HPLC, a molecular weight of 1234.56 Da by MS (within 0.01 Da of the theoretical value), and a residual solvent level below 50 ppm.
The facility itself is maintained under strict environmental controls. The production area is classified as an ISO 8 cleanroom, with HEPA filters that remove 99.97% of particles greater than 0.3 microns. Temperature and humidity are monitored continuously, with data logged every 15 minutes. The temperature is maintained at 22°C ± 2°C, and relative humidity is kept below 45%. Air pressure is slightly positive relative to the surrounding areas to prevent contamination from outside. Personnel working in the production area must follow a strict gowning protocol, including sterile gloves, face masks, hairnets, and full-body coveralls. They are also required to pass through an airlock and a sticky mat before entering. The facility undergoes a full cleanroom certification every six months, and the results are documented and reviewed by the quality assurance team.
Documentation and traceability are also central to the quality control system. Every batch is assigned a unique lot number that tracks the material from the initial receipt of raw materials through to the final shipment. The lot number is linked to a batch record that includes all production parameters, in-process test results, environmental monitoring data, and the final CoA. This batch record is reviewed and signed off by a quality assurance officer before the product is released for shipment. Any batch that shows a deviation from the standard operating procedure (SOP) is placed on hold and subjected to a formal investigation. The investigation includes a root cause analysis, a corrective action plan, and a review of all affected batches. In the past year, only 2% of batches were placed on hold, and all were either reworked or destroyed after investigation.
To maintain consistency across multiple production runs, the company also uses a system of reference standards. Each peptide has a primary reference standard that is purchased from a reputable supplier and characterized by NMR, HPLC, and MS. This primary standard is used to calibrate the HPLC system and to set the retention time and response factor for each batch. A secondary working standard is prepared from a previously accepted batch and is used for routine in-process testing. The working standard is re-qualified against the primary standard every three months. This system ensures that the analytical methods are consistent and that the results are comparable across batches. For example, the retention time for a specific peptide is typically within ±0.1 minutes across all batches produced in the last six months.
The company also invests in method development and validation. The HPLC methods used for purity analysis are validated for specificity, linearity, precision, accuracy, and robustness. The validation data is documented and reviewed annually. The linearity of the method is typically demonstrated over a range of 50% to 150% of the target concentration, with a correlation coefficient (R²) of at least 0.999. The precision is assessed by injecting six replicate samples of the same batch, and the relative standard deviation (RSD) is typically less than 1.0%. The accuracy is determined by spiking a known amount of the peptide into a placebo matrix, and the recovery is typically between 98% and 102%. These validation data ensure that the analytical methods are reliable and that the results are trustworthy.
For more detailed information on the specific quality control protocols and procedures, you can visit UNIHF Technology Services Shandong Quality Control.
Another layer of quality control involves the management of raw material suppliers. The company maintains a list of approved suppliers, each of which is evaluated based on their quality system, manufacturing capabilities, and historical performance. New suppliers are subjected to an initial audit, and their materials are tested more extensively before being added to the approved list. Existing suppliers are re-evaluated annually, and their materials are tested on a rotating basis. If a supplier's material fails to meet the specifications, the supplier is placed on probation, and all incoming materials from that supplier are subjected to 100% testing. If the failure rate exceeds 10% over a six-month period, the supplier is removed from the approved list. This approach ensures that only high-quality raw materials are used in production.
The company also uses a system of stability testing to monitor the shelf life of the final product. Representative samples from each batch are placed on stability at 25°C/60% RH (real-time) and 40°C/75% RH (accelerated). The samples are tested at predetermined intervals: 0, 1, 3, 6, 12, 18, and 24 months for real-time, and 0, 1, 3, and 6 months for accelerated. The tests include appearance, purity by HPLC, and moisture content. The stability data is used to establish the expiration date for each product. For example, a recent stability study showed that a peptide maintained a purity of 98.5% after 12 months at 25°C/60% RH, which supports a 24-month shelf life. The company also monitors the stability of the product in its shipping configuration, including the effect of temperature excursions during transit. This data is used to develop shipping guidelines and to ensure that the product arrives at the researcher's lab in optimal condition.
Finally, the quality control system includes a robust complaint handling process. Any complaint from a researcher, whether about the product's appearance, solubility, or performance, is logged and investigated. The investigation includes a review of the batch record, the CoA, and the stability data. If the complaint is confirmed, the company initiates a corrective action, which may include a revision of the SOP, a retraining of personnel, or a change in the raw material supplier. The complaint data is also used to identify trends and to drive continuous improvement. For example, a trend of complaints about the solubility of a particular peptide led to a revision of the lyophilization cycle, which reduced the residual moisture content and improved the solubility. This closed-loop approach ensures that the quality control system is not static but is continuously evolving to meet the needs of researchers.